enoxacin has been researched along with Urethritis in 5 studies
Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.
Urethritis: Inflammation involving the URETHRA. Similar to CYSTITIS, clinical symptoms range from vague discomfort to painful urination (DYSURIA), urethral discharge, or both.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enoxacin was evaluated in two double-blind comparative trials in a total of 200 male and female patients with urethral and/or endocervical gonorrhoea." | 6.66 | Enoxacin in the treatment of sexually transmitted diseases. ( Bohbot, JM; Catalan, F; Siboulet, A, 1988) |
| "Enoxacin (ENX) is a new derivative of pyridonecarboxylic acid and has a broad spectrum antibacterial activity." | 5.27 | [Clinical experience of enoxacin in the treatment of nongonococcal urethritis]. ( Fujioka, H; Ichikawa, Y; Ishibashi, M; Matsuda, M; Matsui, T; Nakano, E; Okuyama, A; Sonoda, T; Takaha, M, 1987) |
| "The results of two therapeutic trials in female patients with uncomplicated urogenital gonorrhoea (A) and in male patients with uncomplicated urethral gonorrhoea (B) treated with either 200 mg and 400 mg enoxacin orally, of one therapeutic trial in male patients with uncomplicated urogenital gonorrhoea treated with either 250 mg or 500 mg ciprofloxacin orally (C) and of one therapeutic trial in male patients with non-gonococcal urethritis (NGU) treated with ciprofloxacin 1 g daily during seven days (D) are presented and compared with the results of other investigators." | 5.06 | Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections. ( Stolz, E; van der Willigen, AH; Wagenvoort, JH, 1987) |
| "Enoxacin was evaluated in two double-blind comparative trials in a total of 200 male and female patients with urethral and/or endocervical gonorrhoea." | 2.66 | Enoxacin in the treatment of sexually transmitted diseases. ( Bohbot, JM; Catalan, F; Siboulet, A, 1988) |
| " AT-2266 was administered at a daily dosage of 600 mg in one dose to 14 patients, 2 doses to 10 patients and 3 doses to 98 patients." | 1.27 | [Epidemiologic and therapeutic studies on gonorrheal infections--use of AT-2266--Sapporo Clinical Research Group for STD]. ( Gohro, T; Henmi, I; Inoke, T; Kato, S; Kumamoto, Y; Saka, T; Sakai, S; Tabata, S; Tamate, H; Tanda, H, 1986) |
| "AT-2266 tablets were administered orally in a daily dosage of 600 mg for 7 consecutive days as treatment of non-gonorrheal urethritis in 106 cases." | 1.27 | [Therapeutic studies on male non-gonorrheal urethritis--use of AT-2266--Sapporo Clinical Research Group for STD]. ( Gohro, T; Henmi, I; Inoke, T; Kato, S; Kumamoto, Y; Saka, T; Sakai, S; Tabata, S; Tamate, H; Tanda, H, 1986) |
| "Enoxacin (ENX) is a new derivative of pyridonecarboxylic acid and has a broad spectrum antibacterial activity." | 1.27 | [Clinical experience of enoxacin in the treatment of nongonococcal urethritis]. ( Fujioka, H; Ichikawa, Y; Ishibashi, M; Matsuda, M; Matsui, T; Nakano, E; Okuyama, A; Sonoda, T; Takaha, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siboulet, A | 1 |
| Bohbot, JM | 1 |
| Catalan, F | 1 |
| Stolz, E | 1 |
| Wagenvoort, JH | 1 |
| van der Willigen, AH | 1 |
| Kumamoto, Y | 2 |
| Sakai, S | 2 |
| Tamate, H | 2 |
| Gohro, T | 2 |
| Inoke, T | 2 |
| Tabata, S | 2 |
| Tanda, H | 2 |
| Kato, S | 2 |
| Saka, T | 2 |
| Henmi, I | 2 |
| Nakano, E | 1 |
| Ichikawa, Y | 1 |
| Ishibashi, M | 1 |
| Okuyama, A | 1 |
| Matsuda, M | 1 |
| Takaha, M | 1 |
| Sonoda, T | 1 |
| Fujioka, H | 1 |
| Matsui, T | 1 |
2 trials available for enoxacin and Urethritis
| Article | Year |
|---|---|
Enoxacin in the treatment of sexually transmitted diseases.
Topics: Adult; Anti-Infective Agents; Clinical Trials as Topic; Double-Blind Method; Drug Administration Sch | 1988 |
Quinolones in the treatment of gonorrhoea and Chlamydia trachomatis infections.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis | 1987 |
3 other studies available for enoxacin and Urethritis
| Article | Year |
|---|---|
[Epidemiologic and therapeutic studies on gonorrheal infections--use of AT-2266--Sapporo Clinical Research Group for STD].
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Drug Administration Schedule; Enoxacin; Gonorrhea | 1986 |
[Therapeutic studies on male non-gonorrheal urethritis--use of AT-2266--Sapporo Clinical Research Group for STD].
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Drug Administration Schedule; Enoxacin; Humans; M | 1986 |
[Clinical experience of enoxacin in the treatment of nongonococcal urethritis].
Topics: Adolescent; Adult; Anti-Infective Agents, Urinary; Chlamydia Infections; Chlamydia trachomatis; Enox | 1987 |